Presence of teratoma in orchiectomy specimen increases the need for postchemotherapy RPLND


Inci K., DOĞAN H. S., AKDOĞAN B., BAYDAR D., ERGEN A., Ozen H.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, cilt.29, sa.1, ss.38-42, 2011 (SCI-Expanded) identifier identifier identifier

Özet

Objectives: This study was carried out to evaluate the impact of the presence of teratomatous component in orchiectomy specimen on complete response rates to primary chemotherapy in a large series of patients with stage II nonseminomatous germ cell tumors (NSGCT).